CD8A and neoplasm: Adaptive immunity is defined by the presence of either T- or B-lymphocytes, and includes both CD8+ cytotoxic effector T-cells that directly destroy tumor cells, CD4+ helper T-cells that regulate CD8+ T-cell and B-cell function, and B-cells that present antigen and produce antibodies.